If development times for a new brand could be reduced by about 19%, the average cost of developing a drug would be reduced by about $100 million.

Source: Tufts Center for the Study of Drug Development

Clinical Development Business Challenges

• Lack of reliable, consistent information limits clinical program decision making
• Inefficient global and local collaboration with both internal and external organizations
• Limited data transformation and analysis efficiency
• Difficulties enforcing data and analysis standards
• Questionable validation as data moves from source systems through analysis and reporting
• Lack of standard, reusable transformation and analysis routines leads to slow report generation

We have the experts and technology required to solve these development challenges to bring innovation through consulting.

A Data-Driven and Research-Based Approach

• Physiochemical – Captures information on material properties of a drug and technology/dose form compatibility
• Pharmacokinetics- Capture key pharmacokinetic properties of a drug that delivers efficacy
• Patient Considerations – A vision for a product that will meet the needs of the patient
• Dose Form Selection and Manufacturability- Recommendations that consider dose form evolution, product differentiation, and speed to market. Plus, a stable drug product and manufacturing process that is efficient and scalable

Formulation flexibility

• Seamless transition to stable, scalable finished dose forms
• Enhanced therapeutic profiles
• Better absorption
• Faster onset
• Extended and timely release
• Targeted delivery
• Improved therapeutic adherence
• Minimized food effects
• Reduced dose burden
• Reduced dose frequency
• Taste masking technology
• Better dosing experience for special patient groups (e.g. pediatric, geriatric, psychiatric, veterinary
• Unique technologies to attract prescribers and patient